Table 2.
Outcome | Study group n (%) (n = 739) | Control group n (%) (n = 799) | Relative risk (95 % CI) |
---|---|---|---|
Gestational diabetes | 31 (4.2) | 35 (4.4) | 0.93 (0.58–1.50) |
Pre-eclampsia | 33 (4.5) | 20 (2.5) | 1.73 (1.01–3.00) |
Antepartum hemorrhage | 7 (0.9) | 4 (0.5) | 1.84 (0.54–6.28) |
Postpartum hemorrhage | 22 (3.0) | 23 (2.9) | 1.02 (0.57–1.81) |
Preterm birth | 49 (6.6) | 44 (5.5) | 1.17 (0.79–1.74) |
Macrosomia | 37 (5.0) | 58 (7.3) | 0.67 (0.45–1.00) |
IUGR | 13 (1.8) | 13 (1.6) | 1.05 (0.49–2.26) |
Fetal weight <2,500 g | 44 (6.0) | 59 (7.4) | 0.77 (0.53–1.12) |
Stillbirth | 4 (0.5) | 2 (0.3) | 2.14 (0.39–11.67) |
Apgar score ≤7 at 1 min | 35 (4.7) | 46 (5.8) | 0.82 (0.53–1.25) |
Apgar score ≤7 at 5 min | 7 (0.9) | 5 (0.6) | 1.50 (0.48–4.71) |
NICU admission | 12 (1.6) | 12 (1.5) | 1.06 (0.48–2.35) |
Shoulder dystocia | 0 (0) | 2 (0.3) | 000 |
Puerperal morbidity | 8 (1.1) | 5 (0.6) | 1.70 (0.56–5.17) |